Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CytomX Therapeutics (CTMX) Other Non Operating Income: 2013-2024

Historic Other Non Operating Income for CytomX Therapeutics (CTMX) over the last 12 years, with Dec 2024 value amounting to -$38,000.

  • CytomX Therapeutics' Other Non Operating Income rose 171.43% to $5,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $14,000, marking a year-over-year increase of 227.27%. This contributed to the annual value of -$38,000 for FY2024, which is 26.67% down from last year.
  • As of FY2024, CytomX Therapeutics' Other Non Operating Income stood at -$38,000, which was down 26.67% from -$30,000 recorded in FY2023.
  • In the past 5 years, CytomX Therapeutics' Other Non Operating Income registered a high of $340,000 during FY2022, and its lowest value of -$83,000 during FY2021.
  • Its 3-year average for Other Non Operating Income is $90,667, with a median of -$30,000 in 2023.
  • Its Other Non Operating Income has fluctuated over the past 5 years, first plummeted by 207.41% in 2021, then skyrocketed by 509.64% in 2022.
  • Over the past 5 years, CytomX Therapeutics' Other Non Operating Income (Yearly) stood at -$27,000 in 2020, then crashed by 207.41% to -$83,000 in 2021, then spiked by 509.64% to $340,000 in 2022, then crashed by 108.82% to -$30,000 in 2023, then decreased by 26.67% to -$38,000 in 2024.